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ABSTRACT
From August 2004 to July 2005, 210 clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates
were collected prospectively from 173 children admitted to Chang Gung Children’s Hospital in Taiwan.
A comparative molecular analysis of the 111 community-associated (CA) isolates from 102 children and
the 99 healthcare-associated (HA) isolates from 71 children was conducted. In comparison to the HA
isolates (31%), the CA isolates (90%) were more likely to have been isolated from pus (p <5 · 10)8).
For each patient with MRSA infection, only the ﬁrst isolate was selected for molecular analysis.
The molecular characteristics differed signiﬁcantly between the CA and the HA isolates (p <5 · 10)8).
The clone characterized as sequence type (ST)59 ⁄pulsotype D (similar to USA1000) ⁄ staphylococcal
chromosomal cassette (SCC)mec VT ⁄Panton–Valentine leukocidin (PVL)-positive accounted for 69% of
the CA isolates, and another clone, characterized as ST239 ⁄pulsotype A (Hungary clone) ⁄ SCCme-
c III ⁄PVL-negative, accounted for 45% of the 71 HA isolates. The CA clone of ST59 also accounted for
20% of the HA isolates, including 47% of the 17 community-onset isolates. It was concluded that the
molecular characteristics of clinical MRSA isolates from children differed signiﬁcantly between the CA
and the HA isolates in northern Taiwan. However, the CA clone of ST59 was also identiﬁed in a
substantial proportion of HA isolates.
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INTRODUCTION
Recent reports indicate that community-associ-
ated methicillin-resistant Staphylococcus aureus
(CA-MRSA) infections are increasing and may
now involve individuals without risk factors
predisposing for acquisition of MRSA [1–11].
CA-MRSA strains have been recognized as a
novel pathogen group that is genetically different
from nosocomial MRSA [5,8,9,11]. They are usu-
ally characterized by limited antibiotic resistance
(except to b-lactams). They possess different
exotoxin gene proﬁles (e.g. Panton–Valentine
leukocidin (PVL)) and carry the type IV staphy-
lococcal cassette chromosome (SCCmec IV). The
major clinical manifestations are usually cellulitis
and abscesses. However, CA-MRSA clones vary
among different continents, countries, and even
areas. For example, clones of multilocus sequence
type (ST)1 (USA400) and ST8 (USA300) are found
mainly in the USA and Canada [9–14], clones of
ST80 are found mainly in Europe [12,15], and
clones of ST30 are found worldwide, including
the USA, Europe, Oceania and Japan [12,16,17].
In Taiwan, several retrospective studies have
shown that between 1997 and 2003, MRSA
accounted for 9.8–36% of CA S. aureus infections
in children without risk factors [18–21]. Most of
these retrospectively collected CA clinical isolates
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were characterized by a speciﬁc pulsed-ﬁeld gel
electrophoresis (PFGE) pattern (similar to
USA1000) and resistance to clindamycin and
erythromycin. They contain a speciﬁc type of
SCCmec (type VT, recently tentatively designated
as type VII by Takano et al. [17]) gene and possess
PVL genes [22–24]. However, there has been no
prospective study that has systemically collected
and molecularly characterized the CA-MRSA clin-
ical isolates in Taiwan. Therefore, this prospective
studywas conducted to elucidate the situation and
compare the molecular characteristics of the CA
and the healthcare-associated (HA) isolates.
MATERIALS AND METHODS
Chang Gung Children’s Hospital is a university-afﬁliated
hospital, situated in northern Taiwan (near Taipei city), that
provides a range of care, from primary to tertiary, and is part
of Chang Gung Memorial Hospital. Between August 2004 and
July 2005, an investigator (C.-F. Ho) evaluated the medical
records of hospitalized children (excluding those from neona-
tal units) when an MRSA isolate was identiﬁed microbiolog-
ically. The deﬁnitions of CA-MRSA and HA-MRSA infection
used in the study were according to those proposed by Naimi
et al. [5]. MRSA infection identiﬁed after 48 h of hospitalization
or yielding a positive culture from a lesion absent at admission
was categorized as hospital-onset (HO). If the infection was
classiﬁed as community-onset (CO), which was deﬁned as
MRSA infection identiﬁed within 48 h of admission, the
parents or the care provider of the patients were interviewed,
using a questionnaire concerning hospitalization, surgery,
dialysis, a permanent indwelling catheter or percutaneous
medical device, a known MRSA-positive culture before this
infection, and history of residence in a long-term-care facility
within the previous 12 months. Information about household
members working in healthcare facilities was also recorded.
Patients with any of these conditions or with a hospital onset
of MRSA infection were classiﬁed as having HA infections;
otherwise, they were classiﬁed as having CA infections.
Patients less than 1 year of age were classiﬁed as having CA
infections if they did not have any above condition after birth,
except birth in the hospital.
Identiﬁcation of MRSA was conﬁrmed according to CLSI
guidelines [25]. PFGE with SmaI-digested DNA was per-
formed according to the procedures described previously
[19,26,27]. The genotypes were designated in alphabetical
order. PFGE patterns with differences in fewer than four bands
as compared with an existing genotype were deﬁned as
subtypes of that genotype [28].
The SCCmec typing was carried out using a multiplex PCR
strategy described previously [29]. Control strains for SCCmec
types I, II, III and IVa, kindly provided by K. Hiramatsu, were
as follows: type I, NCTC10442; type II, N315; type III, 85 ⁄ 2082;
and type IVa, JCSC4744. SCCmec typing of type VT was
carried out using a particular primer described elsewhere
[24], and the strain TSGH-17, kindly provided by C.-C. Wang,
was used as a control. However, the SCCmec typing method
for type VT yielded inconsistent results. Thus, an alternative
method, described elsewhere, was used [30]. The presence of
PVL genes was determined by a PCR strategy described
previously [31]. Some isolates of representative PFGE patterns
were subjected to multilocus sequence typing (MLST) as
described elsewhere [32]. The allelic proﬁles were assigned by
comparison of the sequences at each locus with those of the
known alleles in the S. aureus MLST database, and were
deﬁned as STs accordingly. The results were analysed statis-
tically by a chi-square test or Fisher’s exact test if appropriate.
A difference was considered signiﬁcant if p <0.05.
RESULTS
During the study period, 394 S. aureus isolates
were identiﬁed from 357 children, and 210 of the
isolates from 173 children were methicillin-resis-
tant (Table 1). Among them, 130 MRSA isolates
from 119 children were classiﬁed as CO, 111
isolates from 102 children were classiﬁed as CA,
and 99 isolates from 71 children were classiﬁed as
HA. Table 2 illustrates the distribution of speci-
mens in which the 210 MRSA isolates were
identiﬁed. Ninety per cent of the 111 CA-MRSA
isolates were from pus, whereas this was the case
in only 31% of the 99 HA-MRSA isolates. Isolates
in the CA group were more likely to have been
recovered from pus (p <5 · 10)8), whereas those
in the HA group were more likely to have been
recovered from blood (p <0.05), sputum
(p <5 · 10)8), and central venous catheters
(p <0.001). Within the HA group, CO infection-
causing MRSA isolates were more likely to be
obtained from pus (p <0.0005), whereas in the
case of the HO infections, MRSA isolates were
more likely to be obtained from sputum (p <0.05).
Of the 102 children with CA-MRSA infections,
47 (46%) were male and 55 (54%) female. Eighty-
eight patients (86%) presented with simple skin
and ⁄ or soft tissue infection. Six patients (5.9%)
had soft tissue infection with a scarlatiniform
rash. Septic arthritis was noted in two cases (both
blood and joint ﬂuid yielded MRSA), pneumonia
in two cases (blood culture yielded MRSA in one
case), necrotizing fasciitis with sepsis in one case
(blood culture positive for MRSA), and varicella
Table 1. Source of Staphylococcus aureus infections in 357
children as related to methicillin resistance
Source
Methicillin-
resistanta
Methicillin-
sensitive Total no.
Community-associated 102 (56) 81 (44) 183
Healthcare-associated 71 (41) 103 (59) 174
Values are given as n (%).
aThe rate of methicillin resistance among community-associated isolates was
signiﬁcantly higher than that among healthcare-associated isolates (p <0.005).
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gangrenosum with septic shock due to MRSA in
one case. Two patients had bacteraemia. None of
the 102 patients died during the study period.
For microbiological characterization, only the
ﬁrst MRSA isolate from a single patient was
included for analysis. The detailed antimicrobial
susceptibility distribution of the isolates is shown
in Table 3. All of the 173 MRSA isolates were
susceptible to vancomycin and teicoplanin but
resistant to penicillin. Most isolates were resistant
to erythromycin and clindamycin. However, CA-
MRSA isolates were signiﬁcantly more suscepti-
ble to trimethoprim–sulphamethoxazole than
were HA-MRSA isolates (p <5 · 10)8).
Table 4 illustrates the detailed distribution of
PFGE patterns, SCCmec types and the presence of
PVL genes in these MRSA isolates. In total, 13
PFGE patterns were identiﬁed; ten patterns were
found among the CA isolates, and nine among the
HA isolates. PFGE pattern D, the most common
pattern among the CA isolates, accounted for 73%
of the CA isolates but only 21% of the HA
isolates. In contrast, pattern A, the most common
pattern among the HA isolates, accounted for
45% of the HA isolates but 4.9% of the CA
isolates. The distribution of PFGE patterns was
signiﬁcantly different between the two groups
(p <5 · 10)8). Four SCCmec types were identiﬁed
Table 3. Antibiotic susceptibility of
173 clinical methicillin-resistant
Staphylococcus aureus isolates strati-
ﬁed according to the origin of acqui-
sition
Origin
No. of
isolates Penicillin Erythromycin Clindamycin
Trimethoprim ⁄
sulfamethoxazolea Vancomycin Teicoplanin
Community-
associated
102 0 6 (5.9) 8 (7.8) 97 (95) 102 (100) 102 (100)
Healthcare-
associated
71 0 2 (2.8) 6 (8.5) 34 (48) 71 (100) 71 (100)
Community-
onset
17 0 0 2 (12) 11 (65) 17 (100) 17 (100)
Hospital-
onset
54 0 2 (3.7) 4 (7.4) 23 (43) 54 (100) 54 (100)
Values are given as n (%).
aThe susceptibility to trimethoprim ⁄ sulfamethoxazole was signiﬁcantly different between the community-
associated and healthcare-associated isolates (p <5 · 10)8).
Table 2. Distribution of 210 clinical
methicillin-resistant Staphylococcus
aureus isolates stratiﬁed according
to specimen types
Origin
No. of
isolates Blood Sputum Pus CVC Urine CSF Othersa
Community-associatedb 111 4 (3.6) 5 (4.5) 100 (90) 0 1 (0.9) 0 1 (0.9)
Healthcare-associatedb 99 13 (13) 37 (37) 31 (31) 9 (9) 4 (4) 3 (3) 2 (2)
Community-onsetc 19 1 (5.3) 3 (16) 13 (68) 0 1 (5.3) 1 (5.3) 0
Hospital-onsetc 80 12 (15) 34 (43) 18 (23) 9 (11) 3 (3.8) 2 (2.5) 2 (2.5)
Values are given as n (%).
CVC, central venous catheter; CSF, cerebrospinal ﬂuid.
aAscites and tissue.
bA signiﬁcant difference was found between the community-associated and healthcare-associated isolates with
respect to the specimens from blood (p < 0.05), CVC (p <0.001), sputum and pus (p <5 · 10)8).
cA signiﬁcant difference was found between the community-onset and hospital-onset isolates with respect to the
specimens from sputum and pus (p <0.05).
Table 4. Comparison of molecular characteristics between community-associated and healthcare-associated methicillin-
resistant Staphylococcus aureus isolates from 173 children
Origin No. of isolates
PFGE pattern SCCmec type
Presence of PVL genesA C D Other II III IV VT
Community-associateda 102 5 (4.9) 12 (12) 74 (73) 11 (11) 3 (2.9) 7 (6.9) 21 (21) 71 (70) 81 (79)
Healthcare-associateda 71 32 (45) 17 (24) 15 (21) 7 (9.9) 1 (1.4) 35 (49) 20 (28) 15 (21) 14 (20)
Community-onsetb 17 3 (18) 5 (29) 8 (47) 1 (5.8) 0 3 (18) 6 (35) 8 (47) 8 (47)
Hospital-onsetb 54 29 (54) 12 (22) 7 (13) 6 (11) 1 (1.9) 32 (59) 14 (26) 7 (13) 6 (11)
Sequence type 239 59 59, 338, newc 5, 8, 22, 30, 59, 89, 239
Values are given as n (%).
PFGE, pulsed-ﬁeld gel electrophoresis; SCCmec, staphylococcal chromosomal cassette; PVL, Panton–Valentine leukocidin.
aA signiﬁcant difference was found between the community-associated and healthcare-associated isolates with respect to PFGE type C (p <0.05), types A and D, and
SCCmec III and VT, and the presence of PVL genes (p <5 · 10)8).
bA signiﬁcant difference was found between the community-onset and hospital-onset isolates with respect to PFGE types A and D, and SCCmec III and VT, and the presence of
PVL genes (p <0.01).
cA single-locus variant of ST1 (single nucleotide difference).
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among the isolates. Type VT was the predominant
type among the CA isolates, whereas type III was
the predominant type among the HA isolates.
PVL genes were detected in 79% of the CA
isolates but in only 20% of the HA isolates. The
distribution of SCCmec types and the presence of
PVL genes were signiﬁcantly different between
the two groups (p <5 · 10)8). A similar picture
was also found when the characteristics of CO
isolates were compared with those of HO isolates
(p <0.01). The molecular characteristics of nearly
half of the CO isolates were the same as those of
CA isolates. However, the molecular characteris-
tics were signiﬁcantly different between the CA
isolates and the CO isolates in terms of PFGE
patterns (p <0.031, using Fisher’s exact test) and
the presence of PVL genes (p <0.012, using the
same test).
MLST was performed for 56 isolates, and nine
STs were identiﬁed (Table 4). ST59 accounted for
30 of the 34 PFGE type D isolates, seven of the
seven PFGE type C isolates, and one each of the
PFGE type AA and PFGE type AN isolates.
ST338, a single-locus variant of ST59 (one nucle-
otide difference in the gmk locus), accounted for
three other isolates of PFGE type D. A PFGE
type D isolate was found to be of a new ST, a
single-locus variant of ST1. ST239 accounted for
all six isolates of PFGE type A subjected to MLST
and one isolate of PFGE type AP. Altogether,
three dominant clones were identiﬁed among the
clinical MRSA isolates; they were characterized as
ST59 ⁄PFGE type D ⁄ SCCmec VT ⁄PVL(+), ST59 ⁄
PFGE type C ⁄ SCCmec IV ⁄PVL()) and ST239 ⁄
PFGE type A ⁄ SCCmec III ⁄PVL()) (Table 5). The
former clone was signiﬁcantly more frequently
found in the CA isolates than in the HA isolates
(p <5 · 10)8). In contrast, the latter clone was
signiﬁcantly more likely to be found in the
HA isolates than in the CA isolates
(p <5 · 10)8).
DISCUSSION
The results from this study indicated that the
microbiological characteristics of MRSA clinical
isolates, including the source of specimens, the
antibiotic susceptibility pattern, the PFGE pat-
terns, the SCCmec types, and the presence of PVL
genes, were signiﬁcantly different between the
CA isolates and the HA isolates in northern
Taiwan. These results suggest that CA-MRSA
isolates in Taiwan had not spread from the
healthcare facilities but originated de novo in the
community. Furthermore, the rate of methicillin
resistance among the CA S. aureus isolates was
even higher than that among the HA isolates
(56% and 41%, respectively, p <0.005), implying
that a CA-MRSA clone had disseminated in the
community in northern Taiwan.
The signiﬁcant difference in the source of the
specimens obtained between the CA and the HA
isolates reﬂected the signiﬁcantly different dis-
ease spectra of the patients. The majority (90%) of
the CA isolates were cultured from pus and,
indeed, 92% of the 102 children with CA-MRSA
infection presented with skin and soft tissue
infections, which is compatible with reports from
the USA [5,6,11]. In contrast, the specimen
sources of the HA isolates were relatively diverse.
Pus was the source of only 31% of the 99 HA
isolates, whereas pneumonia and catheter-related
bacteraemia might account for more than half of
the hospital-associated infections (the numbers
may depend on the source of specimens
obtained).
Table 5. Distribution of three major clones of methicillin-resistant Staphylococcus aureus among the clinical isolates in
northern Taiwan
Origin PFGE D ⁄SCCmec VT ⁄PVL(+) PFGE C ⁄SCCmec IV ⁄PVL()) PFGE A ⁄SCCmec III ⁄PVL())
Sequence type 59 (338)a 59 239
Community-associatedb (n = 102) 70 (69) 9 (8.8) 4 (3.9)
Hospital-associatedb (n = 71) 14 (20) 16 (23) 32 (45)
Community-onsetc (n = 17) 8 (47) 5 (29) 3 (18)
Hospital-onsetc (n = 54) 6 (11) 11 (20) 29 (54)
Values are given as n (%).
PFGE, pulsed-ﬁeld gel electrophoresis; SCCmec, staphylococcal chromosomal cassette; PVL, Panton–Valentine leukocidin.
aST338 is a single-locus variant of ST59 and accounted for three of 33 isolates of PFGE type D undergoing multilocus sequence typing.
bA signiﬁcant difference was found between the community-associated and healthcare-associated isolates in terms of the second clone (p <0.05), and ﬁrst and third clones
(p <5 · 10)8).
cA signiﬁcant difference was found between the community-onset and hospital-onset isolates in terms of the ﬁrst and third clones (p <0.01).
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In the current study, more than 90% of the
clinical MRSA isolates, either CA or HA, were
also resistant to clindamycin and erythromycin.
This scenario is different from that in the USA
[1–11], where most CA-MRSA isolates were
reported to still be susceptible to erythromycin
and clindamycin. Apparently, in Taiwan, for
children with severe diseases possibly caused
by S. aureus infection, clindamycin alone is no
longer appropriate, and a glycopeptide (vanco-
mycin or teicoplanin) or linezolid should be used
empirically. However, more than 90% of the CA
isolates remained susceptible to trimethoprim–
sulphamethoxazole, indicating that oral trimeth-
oprim–sulphamethoxazole may still be suitable
for simple skin and soft tissue infections caused
by CA-MRSA.
The molecular characteristics of the CA-MRSA
isolates were signiﬁcantly different from those of
HA-MRSA isolates in the current study, a picture
similar to that seen in the USA [5,8]. However, the
molecular characteristics of the CA isolates from
Taiwan are totally different from those of isolates
identiﬁed in the USA. Consistent with previous
reports from Taiwan [22–24], CA isolates in the
current study shared a common pulsotype
(type D), which was similar to PFT USA1000. It
belonged to ST59 or its variant ST338, carried a
newly identiﬁed subtype of SCCmec V, called
SCCmec VT (recently tentatively designated as
type VII by Takano et al. [17]), and carried PVL
genes. A clone characterized as ST59 ⁄pulsotype
C ⁄ SCCmec IV ⁄PVL()), although accounting for
fewer than 10% of the CA isolates in the current
study, was the predominant clone among the
colonizing isolates from the healthy children
without risk factors in Taiwan [30,33,34]. The
question of whether the PVL genes, which are
reported to constitute a virulence factor associ-
ated with necrotizing pneumonia and abscesses
[35], may be associated with the ability of the
PVL-positive clone to cause infection requires
further investigation.
Among the HA isolates, an epidemic clone,
previously called the Hungarian or Brazilian
clone and characterized as ST239 ⁄ SCCmec
III ⁄PVL()), was predominant and accounted for
nearly half of the HA isolates in the current study.
This clone of ST239 has prevailed in Taiwanese
hospitals since 1994 [36], and accounted for more
than 70% of the clinical MRSA isolates in Taiwan
between 1997 and 2001 [26,37,38]. However, the
CA clones of ST59 accounted for 45% of the HA
isolates, and the rate reached 76% among the CO
isolates, suggesting that the CA clones of ST59
had spread into hospitals and emerged as an HA
clone that may be a major HA clone in the near
future. A similar scenario has also been reported
in some areas of the USA [39].
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